Gene · 835
Papers3,745
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,745
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gene Regulations upon Hydrogel-Mediated Drug Delivery Systems in Skin Cancers-An Overview. | Gels | 2022 | 36135270 | PubTator, text mining | PubMed |
| Mitochondrial Autoantibodies and the Role of Apoptosis in Pemphigus Vulgaris. | Antibodies (Basel) | 2022 | 36134951 | PubTator, text mining | PubMed |
| Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer's disease, Huntington's disease, or Lewy Body dementia. | PLoS One | 2022 | 36129947 | PubTator, text mining | PubMed |
| The role of machine learning in developing non-magnetic resonance imaging based biomarkers for multiple sclerosis: a systematic review. | BMC Med Inform Decis Mak | 2022 | 36109726 | PubTator, text mining | PubMed |
| Nanomedicine and drug delivery to the retina: current status and implications for gene therapy. | Naunyn Schmiedebergs Arch Pharmacol | 2022 | 36107200 | PubTator, text mining | PubMed |
| Influence of Tamoxifen on Different Biological Pathways in Tumorigenesis and Transformation in Adipose-Derived Stem Cells, Mammary Cells and Mammary Carcinoma Cell Lines-An In Vitro Study. | Cells | 2022 | 36078139 | PubTator, text mining | PubMed |
| Roles of Antimicrobial Peptides in Gynecological Cancers. | Int J Mol Sci | 2022 | 36077500 | PubTator, text mining | PubMed |
| Pro-angiogenic activity of isofuran. | Biosci Biotechnol Biochem | 2022 | 36066914 | PubTator, text mining | PubMed |
| System level modeling and analysis of TNF-α mediated sphingolipid signaling pathway in neurological disorders for the prediction of therapeutic targets. | Front Physiol | 2022 | 36060699 | PubTator, text mining | PubMed |
| The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with ritonavir to reduce COVID-19-related hospitalizations. | Med Chem Res | 2022 | 36060104 | PubTator, text mining | PubMed |
| The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects. | Front Oncol | 2022 | 36052258 | PubTator, text mining | PubMed |
| A meta-analysis of genome-wide gene expression differences identifies promising targets for type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2022 | 36051390 | PubTator, text mining | PubMed |
| PIDDosome-SCAP crosstalk controls high-fructose-diet-dependent transition from simple steatosis to steatohepatitis. | Cell Metab | 2022 | 36041455 | PubTator, text mining | PubMed |
| Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics. | Front Pharmacol | 2022 | 36034846 | PubTator, text mining | PubMed |
| The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer. | J Pers Med | 2022 | 36013176 | PubTator, text mining | PubMed |
| Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in Prostate Cancer. | Int J Mol Sci | 2022 | 36012594 | PubTator, text mining | PubMed |
| Restoring TRAILR2/DR5-Mediated Activation of Apoptosis upon Endoplasmic Reticulum Stress as a Therapeutic Strategy in Cancer. | Int J Mol Sci | 2022 | 36012252 | PubTator, text mining | PubMed |
| Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets. | Int J Mol Sci | 2022 | 36012138 | PubTator, text mining | PubMed |
| Cell Cycle Regulation by Integrin-Mediated Adhesion. | Cells | 2022 | 36010598 | PubTator, text mining | PubMed |
| CK2 and the Hallmarks of Cancer. | Biomedicines | 2022 | 36009534 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/835/papers?page=20